Abstract
Significance Far infrared (IR) has a long history in thermometry and febrile screening. Concerns have been raised recently over the accuracy of non-contact body thermometry. Clinical testing with febrile individuals constitutes the standard performance assessment. This is challenging to replicate, which may have inadvertently allowed approval of IR systems that are unable to detect fevers. The ability to test performance without relying on febrile participants would have ramifications for public health, especially if this discovered undisclosed differences in accuracy in widely used devices.
Aim To identify foundational issues in, demonstrate principles of, and develop test methods for non-contact body thermometry.
Approach We review foundational literature and identify confounds impeding performance of IR thermography (IRT) and non-contact IR thermometry (NCIT) for febrile screening and demonstrate corrections for their effects, which would otherwise be unacceptable. Almost none of the devices we are aware of compensate for these confounds. We reverse-engineer surface-to-body temperature relations for several FDA-cleared NCITs. We note their similarity to recently reported bias-to-normal behavior in other devices and determine range of body temperatures for which the device would produce a "normal" (non-febrile) output. Finally, we generate predictable elevated face temperatures in healthy subjects and demonstrate this in several devices.
Results The surface-to-body relationships for two IRT and one NCIT were linear, while all others exhibited nonlinear bias-to-normal behavior that produce normal temperatures when presented with surface temperatures ranging from hypothermia to moderate-to-severe fever. The test method was used in healthy, non-febrile subjects to generate elevated temperatures corresponding to body temperatures from 97.35F to 102.45F. Three out of five systems had negligible sensitivity.
Conclusions This demonstrates an alternative evaluation method without the limitations and risks of febrile patients. These results indicate many devices may be unusable for body thermometry and may be providing a false sense of security for public health surveillance.
Competing Interest Statement
The first author has a financial stake in the company manufacturing one of the devices used in the study (device #1), a device which is not being marketed for sale as of September 2021. All other authors declare no conflicts or competing interests. These details are included in the disclosure statement at the end of the manuscript.
Funding Statement
Thermal Diagnostics LLC provided all funds and all devices except Device #2, which was provided by Cargill Incorporated.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
St Olaf College Institutional Review Board received our study materials (informed consent, study protocol/analysis plan, recruitment protocol and ethics plan) and Jay Demas, St Olaf Physics and Biology faculty and IRB member, reviewed this study 7/22/2021, and determined this study was of minimal risk and approved the study plans. We obtained and documented informed consent from all volunteers, and all data collection sheets used NFC stickers to link across datasets thus no names or other identifying information was collected. Thermal images were stored in an encrypted filesystem and only summary statistics (peak temperature) were exported for study analyses.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All anonymized data produced in the present work are available upon request to the authors and these data and the study materials (blank informed consent, data collection form and study protocol) is available in a public github repository at https://github.com/erikbeall/elevatedfacestudy2021.
